计算溶液所需的质量、体积或浓度。
| 活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
|---|
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| D127636-5mg |
5mg |
现货 ![]() |
| |
| D127636-10mg |
10mg |
现货 ![]() |
| |
| D127636-50mg |
50mg |
期货 ![]() |
|
| 别名 | 度鲁特韦 |
|---|---|
| 英文别名 | GSK1349572 | DOLUTEGRAVIR [VANDF] | GSK 1349572 | HSDB 8152 | Tivicay (TN) | 2H-Pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide, N-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4R,12aS) | SCHEMBL82071 | Z |
| 规格或纯度 | Moligand™, ≥99% |
| 英文名称 | Dolutegravir (GSK1349572) |
| 生化机理 | Dolutegravir(DTG,GSK1349572)是一种整合酶抑制剂,由葛兰素史克公司(GSK)代表 Shionogi-ViiV Healthcare LLC 开发,用于治疗人类免疫缺陷病毒(HIV)-1 感染。多罗替拉韦(DTG,GSK1349572)主要通过二磷酸尿苷葡萄糖醛酸转移酶(μgT)1A1进行代谢,细胞色素P450(CYP)3A的作用较小,未改变的drμg经肾排出量极低(<剂量的1%)。口服总剂量的 53% 未发生变化地从粪便中排出,但目前尚不清楚其中全部或部分是由于未吸收的 drμg 还是由于一定比例的葡萄糖醛酸轭合物的胆汁排泄,葡萄糖醛酸轭合物可在肠腔中进一步降解形成母体化合物。目前的食品与药物管理局(FDA)肾功能损害研究指南草案规定,即使是那些主要代谢或分泌的药物,也应在肾功能损害的患者中进行药代动力学(PK)研究。抑制外周血单核细胞(PBMCs)中 HIV-1 病毒的复制(EC 50 = 0.51 nM)。 |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 产品介绍 |
S/GSK1349572 inhibits recombinant HIV-1 integrase-catalyzed strand transfer in vitro. S/GSK1349572 potently inhibits HIV replication in cells infected with a self-inactivating PHIV lentiviral vector, such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4. S/GSK1349572 exhibits potent activity against five different nonnucleoside reverse transcription inhibitor--resistant or nucleoside reverse transcription inhibitor--resistant viruses in vitro. S/GSK1349572 shows equivalent activity against two protease inhibitor-resistant viruses similarly to that against wild-type virus.Dolutegravir (GSK1349572)是一种HIV整合酶抑制剂,IC50为2.7 nM,适度有效作用于抗Raltegravir的显著突变体Y143R, Q148K, N155H,和G140S/Q148H。 S/GSK1349572 inhibits recombinant HIV-1 integrase-catalyzed strand transfer in vitro. S/GSK1349572 potently inhibits HIV replication in cells infected with a self-inactivating PHIV lentiviral vector, such as peripheral blood mononuclear cells (PBMCs), MT-4 cells and CIP4. S/GSK1349572 exhibits potent activity against five different nonnucleoside reverse transcription inhibitor--resistant or nucleoside reverse transcription inhibitor--resistant viruses in vitro. S/GSK1349572 shows equivalent activity against two protease inhibitor-resistant viruses similarly to that against wild-type virus. |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| 分子类型 | 小分子 |
|---|---|
| IUPAC Name | (3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide |
| INCHI | InChI=1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/t10-,15+/m1/s1 |
| InChi Key | RHWKPHLQXYSBKR-BMIGLBTASA-N |
| Canonical SMILES | CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O |
| Isomeric SMILES | C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O |
| PubChem CID | 54726191 |
| 分子量 | 419.38 |
| 溶解性 | Soluble in DMSO (84 mg/ml at 25 °C), water (<1 mg/ml at 25 °C), and ethanol (<1 mg/ml at 25 °C). |
|---|---|
| 分子量 | 419.400 g/mol |
| XLogP3 | 2.400 |
| 氢键供体数Hydrogen Bond Donor Count | 2 |
| 氢键受体数Hydrogen Bond Acceptor Count | 8 |
| 可旋转键计数Rotatable Bond Count | 3 |
| 精确质量Exact Mass | 419.129 Da |
| 单同位素质量Monoisotopic Mass | 419.129 Da |
| 拓扑极表面积Topological Polar Surface Area | 99.200 Ų |
| 重原子数Heavy Atom Count | 30 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 829.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 2 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| Nitrogen by Elemental Analysis | 9.7-10.2(%) |
|---|---|
| Purity(HPLC) | 99-100(%) |
| Oxygen by Elemental Analysi | 18.7-19.3(%) |
| Carbon by Elemental Analysis | 56.5-57.5(%) |
| Appearance(D127636) | White to off-white solid |
| NMR spectrum | Conforms to Structure |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 日期 | 货号 |
|---|---|---|---|
| 分析证书 | 24-06-12 | D127636 |
¥995.90
| 1. Ozono S et al.. (2020) Super-rapid quantitation of the production of HIV-1 harboring a luminescent peptide tag.. J Biol Chem, 295 (37): (13023-13030). [PMID:32719008] |